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Fixed drug eruption (FDE) is a cutaneous adverse drug eruption
characterized by skin lesions which recur in the same sites upon re-
exposure to the drug.1,2 It may occur as single or multiple lesions
affecting any part of the body, with predilection for the genitalia,
hands and lips.1 Loxoprofen sodium hydrate3 (LX-P) (Loxonin; Daii-
chi Sankyo Co., Ltd, Tokyo, Japan) is a nonsteroidal anti-
inﬂammatory drug (NSAID) that was approved in Japan in 1986.
Amoxicillin hydrate4 (AMPC) (Sawacillin; Astellas Pharma Inc.,
Tokyo, Japan) is an antibiotic that was approved in Japan in 1974.
Here, we report a case of a 38-year-old man diagnosed with FDE
caused by LX-P.
A 38-year-old man visited the emergency department in our
hospital for diagnosis and treatment of erosions on the lip and
intraoral mucosa that had been present for 3 days. Two weeks
before his ﬁrst visit to the emergency department, he had taken azi-
thromycin hydrate for 1 day, oseltamivir phosphate for 3 days, and
LX-P for 5 days to suppress the symptoms of common cold. On the
following day, he noticed an erosion on the left side of lower lip.
The erosion was healed spontaneously in 3 days. Three days later,
he started taking LX-P for 5 days and AMPC for 1 day because he
still had the symptoms of common cold. During this period, he
noticed a fever over 37 C and severe erosions on the lip and intrao-
ral mucosa. Therefore, he stopped all drugs and visited the emer-
gency department (on day 3 after the onset of second eruption).
The emergency room doctor suspected herpes simplex virus
(HSV) infection and prescribed valacyclovir hydrochloride
1000 mg/day for 5 days. Two days later (on day 5 after the onset
of second eruption), he visited our department.
Deep erosions were present on the left side of lower lip (Fig. 1a),
intraoral mucosa, and glans penis (Fig. 1b) with normal body tem-
perature (36.5 C). There were no clinical ocular symptoms or
erythematous skin lesions. He complained of difﬁculty in mouth
opening because of the severe intraoral pain. He stated that he
noticed new erosions on the glans penis this morning. Laboratory
tests were within normal limits, including liver and kidney func-
tions. The white blood cell count (8800/ml; normal range,
3400e7300/ml), including neutrophils (6590/ml; normal range,
1214e5110/ml), and serum levels of C-reactive protein (0.79 mg/
dl; normal range, 0e0.2 mg/dl) were slightly elevated. The eosino-
phil percentage (0.2%; normal 0e8%) was within normal limits. The
negative serological tests for syphilis and human immunodeﬁ-
ciency virus were seen. No fungal infection on the glans penis
was identiﬁed by a potassium hydroxide test. On the basis of hisPeer review under responsibility of Japanese Society of Allergology.
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licenses/by-nc-nd/4.0/).history and these rapid test results, herpesvirus infections, autoim-
mune blistering diseases such as pemphigus vulgaris and cicatricial
pemphigoid, and FDE or StevenseJohnson syndrome (SJS) caused
by LX-P, AMPC, azithromycin hydrate, or oseltamivir phosphate
were considered. We recommended him to start treatment with
oral steroids in case of SJS, but he refused the treatment. After 3
days (on day 8 after the onset of second eruption), the difﬁculty
in mouth opening as well as the erosions on the lip (Fig. 1c) and
glans penis (Fig. 1d) tended to improve spontaneously. HSV type
1- and 2-speciﬁc antigens were not conﬁrmed in smears on a pre-
pared slide from the scrapings of the erosion of the lip. HSV and
varicella zoster virus showed serological past-infection patterns.
The serum autoantibodies against desmoglein 1 and 3, and bullous
pemphigoid antigen 180 were all negative. Therefore, we excluded
herpesvirus infections and autoimmune blistering diseases.
Lymphocyte transformation tests (LTTs) to azithromycin hydrate
(stimulation index [SI],1.4; normal<1.8) and oseltamivir phosphate
(SI, 1.3) were negative (a negative control, 174 counts per minute
[cpm]; a positive control, 102232 cpm), but the positive LTTs with
LX-P (SI, 2.9) and AMPC (SI, 1.9) were obtained using blood samples
taken 9 days after the onset of second eruption (a negative control,
116 cpm; a positive control, 82788 cpm). Based on these LTTs re-
sults, we diagnosed this case as FDE due to LX-P. On day 13 after
the onset of second eruption, all mucous membrane eruptions
healed completely (Fig. 1e,f).
This patient had no fever and the lesions resolved spontane-
ously in a relatively short period of time. Therefore, SJS was
excluded. Patch tests and drug provocation tests were not per-
formed because the patient refused the examination. There have
been some reports of FDE caused by AMPC.5,6 While there have
been no reports of FDE caused by LX-P in the English language liter-
ature. There have been a few reports of FDE caused by LX-P in the
Japanese language literature.7,8 In Mizuno et al.7 the patch test
with LX-P was negative. However, the positive LTT (SI, 5.6) and pos-
itive oral provocation test with LX-P were conﬁrmed. In Tanaka
et al.8 the patch test with LX-P was positive. The oral provocation
test with LX-P was not performed. There was no description of
LTT with LX-P.
The problem of false positivity in the LTT has been suggested.9
Penicillins like amoxicillin are typical haptens. They modify pro-
teins and these might be stimulatory for some T cells of nonsensi-
tized donors and elicit a slightly enhanced proliferation in exposed
but not sensitized individuals.10 Pichler and Tilch10 proposed an SI
>3 to be judged as positive for beta-lactam reactions. Some NSAIDs
also slightly enhance the proliferation, which is normally explained
by their ability to inhibit prostaglandin E2 synthesis.10 However,
this effect is not seen consistently.10 In the present case, LTT was
positive for both LX-P and AMPC, at a relatively higher level of SIvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
Fig. 1. Clinical photographs (aef). (a, lip; b, glans penis) At ﬁrst visit (on day 5 after the onset of second eruption). (c, lip; d, glans penis) On day 8 after the onset of second eruption.
(e, lip; f, glans penis) On day 26 after the onset of second eruption.
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drug. LTT might be low usability for the diagnosis of FDE. It was re-
ported to be rarely positive in patients with FDE.10 However, LTT is
still considered useful in case the patients with FDE refuse patch
tests and drug provocation tests. This case illustrates the impor-
tance of medical practitioners being aware of LX-P as potential
causes of FDE.
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